Clinical Trial Update: Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

Phase 1 study of volasertib in Japanese patients with acute myeloid leukemia; the report covers safety, tolerability, and preliminary activity, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Volasertib (Volasertib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: COMPLETED | Results posted: 2018-07-30